PHILADELPHIA, PA / ACCESSWIRE / November 25, 2022 / Kaskela Law LLC announces that it is investigating Xtant Medical Holdings Inc. ('Xtant') (NYSE:XTNT) on behalf of the Company's investors.
Since July 2021, shares of Xtant's common stock have declined in value from a trading price of $2.00 per share to a current trading price of less than $0.70 per share, a cumulative decline of over 65% in value.
The investigation seeks to determine whether Xtant and/or the company's representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to Xtant investors, thereby causing investor losses.
Xtant stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (email@example.com) or online at https://kaskelalaw.com/cases/xtant-medical-holdings-inc/ , for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
SOURCE: Kaskela Law LLC
View source version on accesswire.com: